Laparoscopic vs Percutaneous Cryotherapy for Renal Tumors: A Systematic Review and Meta-Analysis

Cryoablation has emerged as an alternative to the more invasive partial nephrectomy for small renal masses. The approach can be carried out by two techniques, either laparoscopic cryoablation (LCA) or percutaneous cryoablation, (PCA) with CT guidance. We aimed to compare between the two procedures....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of endourology 2018-03, Vol.32 (3), p.177-183
Hauptverfasser: Aboumarzouk, Omar M, Ismail, Mohamed, Breen, David J, Van Strijen, Marco, Garnon, Julien, Lagerveld, Brunolf, Nielsen, Tommy Kjærgaard, Keeley, Jr, Francis Xavier
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 183
container_issue 3
container_start_page 177
container_title Journal of endourology
container_volume 32
creator Aboumarzouk, Omar M
Ismail, Mohamed
Breen, David J
Van Strijen, Marco
Garnon, Julien
Lagerveld, Brunolf
Nielsen, Tommy Kjærgaard
Keeley, Jr, Francis Xavier
description Cryoablation has emerged as an alternative to the more invasive partial nephrectomy for small renal masses. The approach can be carried out by two techniques, either laparoscopic cryoablation (LCA) or percutaneous cryoablation, (PCA) with CT guidance. We aimed to compare between the two procedures. A systematic review and meta-analysis was conducted, including studies comparing the two techniques. Outcomes included incomplete ablation, late local recurrence, cancer-specific survival, procedure time, transfusion rates, hospital stay, and complications. A total of 1475 patients were included, 788 patients in the laparoscopic group and 687 patients in the percutaneous group. There was statistical difference favoring the laparoscopic group with regard to having less incomplete ablation (p = 0.0008) and higher cancer-specific survival patients (p = 0.04). However, there was longer hospital stays in the LCA group (p 
doi_str_mv 10.1089/end.2017.0791
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1974013250</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1974013250</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-6031ebbc737f6dc630037062212191488df991883b302ee7966eca3d2f8f462b3</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRS0EouWxZIu8ZJMytls7ZldVvKQiUCkSu-A4ExGUF3ZSlL_HVQurWcyZq7mHkAsGEwaxvsY6m3BgagJKswMyZrOZijTA-yEZhz2PlNIwIifefwEwIZk4JiOuOeNCijH5WJrWuMbbpi0s3Xj6gs72namx6T1duKHpPtGZdqB54-gKa1PSdV81zt_QOX0dfIeV6cLpCjcF_lBTZ_QJOxPNAzn4wp-Ro9yUHs_385S83d2uFw_R8vn-cTFfRlYI3kUSBMM0tUqoXGZWCgChQPLwJ9NsGsdZrjWLY5EK4IhKS4nWiIzncT6VPBWn5GqX27rmu0ffJVXhLZblrkrCtJqG_nwGAY12qA3FvcM8aV1RGTckDJKt1CRITbZSk63UwF_uo_u0wuyf_rMofgG8LHI2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1974013250</pqid></control><display><type>article</type><title>Laparoscopic vs Percutaneous Cryotherapy for Renal Tumors: A Systematic Review and Meta-Analysis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Aboumarzouk, Omar M ; Ismail, Mohamed ; Breen, David J ; Van Strijen, Marco ; Garnon, Julien ; Lagerveld, Brunolf ; Nielsen, Tommy Kjærgaard ; Keeley, Jr, Francis Xavier</creator><creatorcontrib>Aboumarzouk, Omar M ; Ismail, Mohamed ; Breen, David J ; Van Strijen, Marco ; Garnon, Julien ; Lagerveld, Brunolf ; Nielsen, Tommy Kjærgaard ; Keeley, Jr, Francis Xavier</creatorcontrib><description>Cryoablation has emerged as an alternative to the more invasive partial nephrectomy for small renal masses. The approach can be carried out by two techniques, either laparoscopic cryoablation (LCA) or percutaneous cryoablation, (PCA) with CT guidance. We aimed to compare between the two procedures. A systematic review and meta-analysis was conducted, including studies comparing the two techniques. Outcomes included incomplete ablation, late local recurrence, cancer-specific survival, procedure time, transfusion rates, hospital stay, and complications. A total of 1475 patients were included, 788 patients in the laparoscopic group and 687 patients in the percutaneous group. There was statistical difference favoring the laparoscopic group with regard to having less incomplete ablation (p = 0.0008) and higher cancer-specific survival patients (p = 0.04). However, there was longer hospital stays in the LCA group (p &lt; 0.00001) and was found to be more costly than the PCA group. There was significantly more Clavien-I complications in the PCA group (p = 0.001) and more Clavien-III complications in the LCA group (p = 0.001). Otherwise, there were no differences in any other outcome parameter. LCA was found to have less incomplete tumor ablation rates and higher cancer-specific survival rates, however, higher hospitalization time, more major complications (Clavien III), and was costlier compared with PCA.</description><identifier>ISSN: 0892-7790</identifier><identifier>EISSN: 1557-900X</identifier><identifier>DOI: 10.1089/end.2017.0791</identifier><identifier>PMID: 29212363</identifier><language>eng</language><publisher>United States</publisher><subject>Aged ; Aged, 80 and over ; Cryotherapy - methods ; Female ; Humans ; Kidney Neoplasms - surgery ; Laparoscopy - methods ; Length of Stay - statistics &amp; numerical data ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Nephrectomy - methods ; Operative Time ; Survival Rate</subject><ispartof>Journal of endourology, 2018-03, Vol.32 (3), p.177-183</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c332t-6031ebbc737f6dc630037062212191488df991883b302ee7966eca3d2f8f462b3</citedby><cites>FETCH-LOGICAL-c332t-6031ebbc737f6dc630037062212191488df991883b302ee7966eca3d2f8f462b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29212363$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aboumarzouk, Omar M</creatorcontrib><creatorcontrib>Ismail, Mohamed</creatorcontrib><creatorcontrib>Breen, David J</creatorcontrib><creatorcontrib>Van Strijen, Marco</creatorcontrib><creatorcontrib>Garnon, Julien</creatorcontrib><creatorcontrib>Lagerveld, Brunolf</creatorcontrib><creatorcontrib>Nielsen, Tommy Kjærgaard</creatorcontrib><creatorcontrib>Keeley, Jr, Francis Xavier</creatorcontrib><title>Laparoscopic vs Percutaneous Cryotherapy for Renal Tumors: A Systematic Review and Meta-Analysis</title><title>Journal of endourology</title><addtitle>J Endourol</addtitle><description>Cryoablation has emerged as an alternative to the more invasive partial nephrectomy for small renal masses. The approach can be carried out by two techniques, either laparoscopic cryoablation (LCA) or percutaneous cryoablation, (PCA) with CT guidance. We aimed to compare between the two procedures. A systematic review and meta-analysis was conducted, including studies comparing the two techniques. Outcomes included incomplete ablation, late local recurrence, cancer-specific survival, procedure time, transfusion rates, hospital stay, and complications. A total of 1475 patients were included, 788 patients in the laparoscopic group and 687 patients in the percutaneous group. There was statistical difference favoring the laparoscopic group with regard to having less incomplete ablation (p = 0.0008) and higher cancer-specific survival patients (p = 0.04). However, there was longer hospital stays in the LCA group (p &lt; 0.00001) and was found to be more costly than the PCA group. There was significantly more Clavien-I complications in the PCA group (p = 0.001) and more Clavien-III complications in the LCA group (p = 0.001). Otherwise, there were no differences in any other outcome parameter. LCA was found to have less incomplete tumor ablation rates and higher cancer-specific survival rates, however, higher hospitalization time, more major complications (Clavien III), and was costlier compared with PCA.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cryotherapy - methods</subject><subject>Female</subject><subject>Humans</subject><subject>Kidney Neoplasms - surgery</subject><subject>Laparoscopy - methods</subject><subject>Length of Stay - statistics &amp; numerical data</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local</subject><subject>Nephrectomy - methods</subject><subject>Operative Time</subject><subject>Survival Rate</subject><issn>0892-7790</issn><issn>1557-900X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMtOwzAQRS0EouWxZIu8ZJMytls7ZldVvKQiUCkSu-A4ExGUF3ZSlL_HVQurWcyZq7mHkAsGEwaxvsY6m3BgagJKswMyZrOZijTA-yEZhz2PlNIwIifefwEwIZk4JiOuOeNCijH5WJrWuMbbpi0s3Xj6gs72namx6T1duKHpPtGZdqB54-gKa1PSdV81zt_QOX0dfIeV6cLpCjcF_lBTZ_QJOxPNAzn4wp-Ro9yUHs_385S83d2uFw_R8vn-cTFfRlYI3kUSBMM0tUqoXGZWCgChQPLwJ9NsGsdZrjWLY5EK4IhKS4nWiIzncT6VPBWn5GqX27rmu0ffJVXhLZblrkrCtJqG_nwGAY12qA3FvcM8aV1RGTckDJKt1CRITbZSk63UwF_uo_u0wuyf_rMofgG8LHI2</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Aboumarzouk, Omar M</creator><creator>Ismail, Mohamed</creator><creator>Breen, David J</creator><creator>Van Strijen, Marco</creator><creator>Garnon, Julien</creator><creator>Lagerveld, Brunolf</creator><creator>Nielsen, Tommy Kjærgaard</creator><creator>Keeley, Jr, Francis Xavier</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201803</creationdate><title>Laparoscopic vs Percutaneous Cryotherapy for Renal Tumors: A Systematic Review and Meta-Analysis</title><author>Aboumarzouk, Omar M ; Ismail, Mohamed ; Breen, David J ; Van Strijen, Marco ; Garnon, Julien ; Lagerveld, Brunolf ; Nielsen, Tommy Kjærgaard ; Keeley, Jr, Francis Xavier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-6031ebbc737f6dc630037062212191488df991883b302ee7966eca3d2f8f462b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cryotherapy - methods</topic><topic>Female</topic><topic>Humans</topic><topic>Kidney Neoplasms - surgery</topic><topic>Laparoscopy - methods</topic><topic>Length of Stay - statistics &amp; numerical data</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local</topic><topic>Nephrectomy - methods</topic><topic>Operative Time</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aboumarzouk, Omar M</creatorcontrib><creatorcontrib>Ismail, Mohamed</creatorcontrib><creatorcontrib>Breen, David J</creatorcontrib><creatorcontrib>Van Strijen, Marco</creatorcontrib><creatorcontrib>Garnon, Julien</creatorcontrib><creatorcontrib>Lagerveld, Brunolf</creatorcontrib><creatorcontrib>Nielsen, Tommy Kjærgaard</creatorcontrib><creatorcontrib>Keeley, Jr, Francis Xavier</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of endourology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aboumarzouk, Omar M</au><au>Ismail, Mohamed</au><au>Breen, David J</au><au>Van Strijen, Marco</au><au>Garnon, Julien</au><au>Lagerveld, Brunolf</au><au>Nielsen, Tommy Kjærgaard</au><au>Keeley, Jr, Francis Xavier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Laparoscopic vs Percutaneous Cryotherapy for Renal Tumors: A Systematic Review and Meta-Analysis</atitle><jtitle>Journal of endourology</jtitle><addtitle>J Endourol</addtitle><date>2018-03</date><risdate>2018</risdate><volume>32</volume><issue>3</issue><spage>177</spage><epage>183</epage><pages>177-183</pages><issn>0892-7790</issn><eissn>1557-900X</eissn><abstract>Cryoablation has emerged as an alternative to the more invasive partial nephrectomy for small renal masses. The approach can be carried out by two techniques, either laparoscopic cryoablation (LCA) or percutaneous cryoablation, (PCA) with CT guidance. We aimed to compare between the two procedures. A systematic review and meta-analysis was conducted, including studies comparing the two techniques. Outcomes included incomplete ablation, late local recurrence, cancer-specific survival, procedure time, transfusion rates, hospital stay, and complications. A total of 1475 patients were included, 788 patients in the laparoscopic group and 687 patients in the percutaneous group. There was statistical difference favoring the laparoscopic group with regard to having less incomplete ablation (p = 0.0008) and higher cancer-specific survival patients (p = 0.04). However, there was longer hospital stays in the LCA group (p &lt; 0.00001) and was found to be more costly than the PCA group. There was significantly more Clavien-I complications in the PCA group (p = 0.001) and more Clavien-III complications in the LCA group (p = 0.001). Otherwise, there were no differences in any other outcome parameter. LCA was found to have less incomplete tumor ablation rates and higher cancer-specific survival rates, however, higher hospitalization time, more major complications (Clavien III), and was costlier compared with PCA.</abstract><cop>United States</cop><pmid>29212363</pmid><doi>10.1089/end.2017.0791</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0892-7790
ispartof Journal of endourology, 2018-03, Vol.32 (3), p.177-183
issn 0892-7790
1557-900X
language eng
recordid cdi_proquest_miscellaneous_1974013250
source MEDLINE; Alma/SFX Local Collection
subjects Aged
Aged, 80 and over
Cryotherapy - methods
Female
Humans
Kidney Neoplasms - surgery
Laparoscopy - methods
Length of Stay - statistics & numerical data
Male
Middle Aged
Neoplasm Recurrence, Local
Nephrectomy - methods
Operative Time
Survival Rate
title Laparoscopic vs Percutaneous Cryotherapy for Renal Tumors: A Systematic Review and Meta-Analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T12%3A06%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Laparoscopic%20vs%20Percutaneous%20Cryotherapy%20for%20Renal%20Tumors:%20A%20Systematic%20Review%20and%20Meta-Analysis&rft.jtitle=Journal%20of%20endourology&rft.au=Aboumarzouk,%20Omar%20M&rft.date=2018-03&rft.volume=32&rft.issue=3&rft.spage=177&rft.epage=183&rft.pages=177-183&rft.issn=0892-7790&rft.eissn=1557-900X&rft_id=info:doi/10.1089/end.2017.0791&rft_dat=%3Cproquest_cross%3E1974013250%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1974013250&rft_id=info:pmid/29212363&rfr_iscdi=true